Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HUMAN GENOME SCIENCES INC | 180,000 | reported | 11 Sept 2003 | tx 1+180,000 |
| Intellia Therapeutics, Inc. | 93,764 | reported | 17 Dec 2020 | tx 17+201,528−177,528 |
| CELGENE CORP /DE/ | 66,432 | reported | 17 Dec 2015 | tx 84+599,429−675,741 |
| NEOPROBE CORP | 37,528 | reported | 16 Jul 2015 | tx 5+59,528−22,000 |
| AGIOS PHARMACEUTICALS, INC. | 23,125 | reported | 23 Jun 2015 | tx 2+23,125 |
| LENZ Therapeutics, Inc. | 20,000 | reported | 19 Jul 2023 | tx 7+161,381−19,763 |
| Voyager Therapeutics, Inc. | 15,000 | reported | 13 Jun 2019 | tx 4+60,000 |
| OncoMed Pharmaceuticals Inc | 0 | reported | 23 Apr 2019 | tx 8+275,689−80,500 |
| Jounce Therapeutics, Inc. | 0 | reported | 03 May 2023 | tx 15+99,200−177,590 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Jul 2023 | GRANT_AWARD | LENZ Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 03 May 2023 | TENDER | Jounce Therapeutics, Inc. | 5,000 | — | |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 15,700 | — | deriv |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 20,000 | — | deriv |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 15,700 | — | deriv |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 15,700 | — | deriv |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 13,350 | — | deriv |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 16,260 | — | deriv |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 75,880 | — | deriv |
| 24 Jun 2022 | GRANT_AWARD | Jounce Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 21 Jun 2022 | GRANT_AWARD | LENZ Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 29 Jun 2021 | CONVERSION | LENZ Therapeutics, Inc. | 8,126 | — | |
| 13 Jan 2021 | GRANT_AWARD | LENZ Therapeutics, Inc. | 74,794 | 0.00 USD | deriv |
| 11 Mar 2021 | GRANT_AWARD | LENZ Therapeutics, Inc. | 19,763 | 5.06 USD | deriv |
| 29 Jun 2021 | CONVERSION | LENZ Therapeutics, Inc. | 19,763 | 0.00 USD | deriv |
| 17 Mar 2021 | GRANT_AWARD | LENZ Therapeutics, Inc. | 18,698 | 0.00 USD | deriv |
| 18 Jun 2021 | GRANT_AWARD | Jounce Therapeutics, Inc. | 15,700 | 0.00 USD | deriv |
| 17 Dec 2020 | SALE | Intellia Therapeutics, Inc. | 21,978 | 52.52 USD | |
| 17 Dec 2020 | EXERCISE | Intellia Therapeutics, Inc. | 31,764 | 18.00 USD | |
| 17 Dec 2020 | EXERCISE | Intellia Therapeutics, Inc. | 19,000 | 25.98 USD | |
| 17 Dec 2020 | EXERCISE | Intellia Therapeutics, Inc. | 19,000 | 15.78 USD | |
| 17 Dec 2020 | EXERCISE | Intellia Therapeutics, Inc. | 19,000 | 14.35 USD | |
| 17 Dec 2020 | SALE | Intellia Therapeutics, Inc. | 45,450 | 53.69 USD | |
| 17 Dec 2020 | SALE | Intellia Therapeutics, Inc. | 21,336 | 54.33 USD | |
| 17 Dec 2020 | EXERCISE | Intellia Therapeutics, Inc. | 31,764 | 0.00 USD | deriv |